Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,000
Closed -$118K 336
2018
Q4
$118K Hold
25,000
0.03% 310
2018
Q3
$159K Hold
25,000
0.04% 332
2018
Q2
$174K Buy
+25,000
New +$160K 0.04% 322

Other funds holding IRIX

Smith, Moore & Co's IRIX Position: Q1 2019 in Review

Smith, Moore & Co sold out of IRIDEX (IRIX) in Q1 2019, closing a stake of 25,000 shares — an estimated $118K sold.

Smith, Moore & Co first reported a position in IRIX in Q2 2018 and held it in 3 quarters. The position peaked at $174K in Q2 2018. 34 funds tracked by Wall St. Rank hold IRIX as of Q1 2019.

  • Smith, Moore & Co reported no remaining IRIDEX position as of Q1 2019 after selling out during the quarter.
  • Smith, Moore & Co sold 25,000 IRIDEX shares in Q1 2019, an estimated $118K.
  • Smith, Moore & Co first reported a position in IRIDEX in Q2 2018 and held it in 3 quarters.
  • Smith, Moore & Co's IRIDEX position peaked at $174K in Q2 2018.
  • 34 funds tracked by Wall St. Rank held IRIDEX as of Q1 2019.

Based on Smith, Moore & Co's 13F filing for Q1 2019, filed 7 May 2019.